Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of melatonin pretreatment in organ donors on liver transplant outcomes
2011-000991-33Phase 3Active
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in liver transplant comparing Melatonin donor pretreatment with Placebo donor pretreatment (2 arms). Primary endpoints: AST levels, ALT levels and 2 more. Started Mar 2012; status: active.
02
Drugs
melatonin
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2011-000991-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000991-33.